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The cDNA of a Schistosoma japonicum myophilin-like protein was cloned, sequenced, and expressed in Escherichia coli as a recom-
bined protein (rSj myophilin-like protein), and the protein was puriﬁed by aﬃnity chromatography. The deduced amino acid sequences
of the Sj myophilin-like protein showed signiﬁcant homology to myophilin, calponin, Np22 and Mp20. Northern blot and RT-PCR ana-
lyzes revealed expression of the Sj myophilin-like protein mRNA in eggs, sporocysts, cercariae, hepatic schistosomula and adult worms.
Confocal ﬂuorescence microscopy localized the native protein to the muscle of the adult worm. In schistosome-infected rabbits, the rSj
myophilin-like protein antibody level, assessed by ELISA, was elevated after infection but was reduced after praziquantel treatment. In
humans, the myophilin-like protein antibody level was evaluated by ELISA in sera from 33 non-infected humans and 61 schistosomiasis
patients; the results showed a highly signiﬁcant diﬀerence between the two groups with a sensitivity of 57.4%. Taken together, the myo-
philin-like protein may prove useful for monitoring the therapeutic eﬀect of praziquantel rather than in serodiagnosis of schistosomiasis.
 2008 Elsevier Inc.
Index Descriptors and Abbreviations: Schistosoma japonicum; Protein Sj myophilin-like; Myophilin-like protein; Schistosomiasis; Serodiagnosis; Immu-
noﬂuorescence; ELISA, enzyme-linked immunosorbent assay; SDS–PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis; RT-PCR, reverse
transcription-polymerase chain reaction; OCT, optimal cutting temperature; PVDF, polyvinylidene diﬂuoride; PBST, phosphate buﬀer solution Tween;
AP, alkaline phosphatase; HRP, horseradish peroxidase; IPTG, isopropyl-b-D-galactopyranoside; FITC, ﬂuorescein sothiocynate
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Schistosomiasis remains a serious public health prob-
lem worldwide, infecting more than 200 million people,0014-4894  2008 Elsevier Inc.
doi:10.1016/j.exppara.2008.01.017
* Corresponding author. Address: Shanghai Institute of Hematology,
Ruijin Hospital, State Key Laboratory of Medical Genomics, Shanghai
Jiao Tong University School of Medicine, Shanghai, China. Fax: +86 21
51320297.
E-mail address: qinghua_zhang@shbiochip.com (Q. Zhang).
Open access under CC BY license.mostly in tropical regions, and is endemic in 74 develop-
ing nations. Schistosoma japonicum is endemic in China
and the Philippines, and is also found in Sulawesi, Indo-
nesia (Savioli et al., 2002; Ross et al., 2002; Engels et al.,
2002; Chitsulo et al., 2004). Correct diagnosis is funda-
mental for controlling schistosomiasis, including case
detection and resulting community treatment, assessment
of morbidity and the evaluation of control strategies. At
present, parasitological and immunological tests are con-
sidered as the main methods in schistosomiasis diagnosis.
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indicates the presence of the worms. However, disadvan-
tages of this relatively time-consuming approach are well
recognized, including high ﬂuctuation in egg counts and
easily missed low infections, (Kongs et al., 2001; Ross
et al., 2001). Immunodiagnostic techniques, on the other
hand, have the advantages of much higher sensitivity
and ease of performance (Ross et al., 2001; Bergquist,
1992; Wu, 2002) and many antibody assays have been
developed (Xiao et al., 2003; van Dam et al., 2004; Stot-
hard et al., 2006). However, few serological tests are com-
mercially available, and the preparation of antigens from
parasites requires the maintenance of the complete para-
sitic cycle and often tedious laboratory extraction proce-
dures. In the past decade, recombinant schistosome
antigen-based serodiagnostic assays have been developed
(Moser et al., 1992; Liu et al., 1993; Hu et al., 2003a,b),
but more speciﬁc and sensitive antigen preparations are
required to develop assays with improved performance.
In addition, although praziquantel-based chemotherapy
(Go¨nnert and Andrews, 1977; Kihara et al., 2007) is the
best regimen available today for the clinical management
of schistosomiasis and is highly eﬀective against all of the
human schistosomes (Geerts and Gryseels, 2000; Kihara
et al., 2007), few simple and eﬀective methods for
monitoring the therapeutic eﬀect of praziquantel are
available.
Using data from the published genomic and cDNA
sequences for S. japonicum (Hu et al., 2003a,b), we identi-
ﬁed a gene encoding a myophilin-like protein (GenBank
Accession No.: AY223463). Here we report the prokary-
otic expression and puriﬁcation of this S. japonicum myo-
philin (rSj myophilin), its functional evaluation of its
potential rabbit models. In addition, immunolocalization
of the Sj myophilin-like was reported.
2. Materials and methods
2.1. Preparation of schistosome samples for analysis
A Chinese isolate of S. japonicum was collected from
Anhui province, China, and the life cycle was maintained
in Oncomelania hupensis snails and Kunming strain mice
at the Institute of Parasitic Disease, Shanghai. mRNA
samples from eggs, sporocysts, cercaria, hepatic schisto-
somula and adult worms, and the native soluble
proteins from adult worms of S. japonicum were prepared
as previously described (Hu et al., 2003a,b; Liu et al.,
2006, 2007).
2.2. Sequence similarity comparison
Online BLAST was used to ﬁnd homologous sequences
of the S. japonicum myophilin-like cDNA and protein.
The sequences were aligned using CLUSTAL(1.0)
multiple sequence alignment programs (http://us.exp-
asy.org/).2.3. Construction of recombined plasmid pET22b-Sj
myophilin-like and pBluescript-Sj myophilin-like
The S. japonicum myophilin-like cDNA was PCR ampli-
ﬁed with primers ﬂanked with BamHI and XhoI (F 50-GC
GTCAGGGATCCGATGGCTAATCAACCT TTAG-30,
R 50-GCGTCTGCTCGAGATCAAGAATCATACGTTG
-30) from the S. japonicum cDNA clone pBluescript II
SK(+) sjs2-011 C10 and subcloned into the pET22b expres-
sion vector and pBluescript II SK(+), respectively. The sub-
cloned protein coding sequences (CDS) were veriﬁed to be
mutation free by sequencing.
2.4. Heterogeneous expression and puriﬁcation of rSj
myophilin-like protein
Recombinant CDS expression was performed following
published procedures (Sambrook and Russell, 2001) with
minor modiﬁcations. Brieﬂy, the recombinant plasmid
pET22b-Sj myophilin-like was transformed into Esche-
richia coli BL21 (DE3), and then the cells were grown,
reaching an optical density of 0.6 at 600 nm, and induced
with 0.8 mM IPTG at 30 C for an additional 4 h. After
incubation, the culture was harvested and processed
according to published protocols (Marshak et al., 1996)
to obtain a pellet of inclusion bodies. Then the inclusion
bodies were dissolved in loading buﬀer containing 6 M gua-
nidine hydrochloride, after centrifugation at 4 C
(8000 rpm, 30 min), the supernatant was ﬁltered through
a 0.45-lm-pore-size ﬁlter before being loaded onto a Che-
lating Sepharose Fast Flow column (GE Healthcare,
USA). After washing the column, the adsorbed recombi-
nant protein was eluted using four steps of increased imid-
azole concentration in elution buﬀer. Fractions were
analyzed by SDS–PAGE and stained with Coomassie blue
to assess their purity.
2.5. RT-PCR
Total RNA (1–5 lg) from each S. japonicum stage was
reverse-transcribed using a SuperScriptTM II Reverse Tran-
criptase system (Invitrogen, USA) and oligo (dT). The
resulting cDNAs and speciﬁc oligonucleotide primers (F
50-GCGTCAGGGATCCGATGGCTAATCAACCTTTA
G-30 and R 50-GCGTCTGCTCGAGATCAAGAATC
ATACGTTG-30) were used in a PCR reaction to amplify
a 570 bp fragment using an EX-Taq DNA polymerase sys-
tem (TAKARA, Dalian, China). The PCR products were
analyzed on a 1% agarose gel.
2.6. Northern blot analysis
Northern blot analysis was performed using a non-Iso-
topic DIG Northern Starter Kit (Roche Diagnostics,
USA) as previously described (Li et al., 2006). Speciﬁcally,
3 lg of total RNA (from adult male worms) per lane were
loaded for electrophoresis and the pBluescript-Sj myophi-
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generation.
2.7. Preparation of polyclonal mouse anti-Sj myophilin-like
serum
Polyclonal mouse antisera were prepared by genetic-
immunization using a DNA prime-protein boost strategy
(Peng et al., 2007). Brieﬂy, mice (Balb/c, female, 6 weeks)
were injected intramuscularly 3 times with 100 lg recom-
bined-plasmid pVAX1-Sj myophilin-like followed by
boosting with 50 lg of rSj myophilin-like protein at 2
weeks intervals. Serum was collected 3 days after the ﬁnal
boost.
2.8. Immunoﬂuorescence assay
Immunoﬂuorescence assays were performed as previ-
ously described (Liu et al., 2006) with some modiﬁcations.
Four-micron-thick frozen sections of adult worms were
embedded in OCT compound and ﬁxed with methanol
for 20 min at room temperature. Slides were blocked with
goat serum overnight at 4 C, and incubated in a humid
atmosphere at room temperature for 2 h with the anti-Sj
myophilin-like serum (1:400 in 0.1% PBST) or pre-immu-
nized mouse serum. The slides were washed twice and incu-
bated for 2 h with 1:80 FITC-conjugated goat anti-mouse
IgG (Sigma, USA), containing 20 lg/ml Evans blue in a
humid atmosphere2 at room temperature. Confocal ﬂuo-
rescence microscopy (Zeiss 510 Meta, German) was used
in visualization of antibody staining.
2.9. Human and rabbit sera
Human sera were obtained from 61 patients with schis-
tosomiasis japonica, conﬁrmed by Kato–Katz stool exam-
ination (Katz et al., 1970), from endemic area in Jiangxi
Province. Control sera were obtained from 33 volunteers
without schistosomiasis from a non-endemic area in
Shanghai.
Seventeen rabbits were exposed to an average of 1000
cercariae per rabbit; nine of these infected rabbits were
treated with praziquantel (administered orally at a dose
of 200 mg/kg body weight) 10 weeks after infection. Serum
samples from the rabbits were collected by lateral ear vein
puncture at 3 weekly intervals.
2.10. Western blotting
SDS–PAGE (10%) was used to analyze the recombi-
nant or native Sj myophilin-like proteins. Aliquots of
puriﬁed rSj myophilin-like (50 ng/well) or crude extracts
(10 lg/well) were loaded onto gels. After electrophoresis,
the gels were either Coomassie blue-stained to visualize
the protein bands or electro-transferred onto PVDF mem-
branes (Millipore, USA) and reacted with antibody
probes. PVDF membranes were blocked for 1 h in 0.1%-PBST containing 5% milk powder and immunostained
with human sera (1:100 in 0.1%-PBST) or mouse poly-
clonal antiserum (1:4000 in 0.1%-PBST). Then, the mem-
branes were washed 3 times in 0.1%-PBST for 15 min and
incubated with aﬃnity puriﬁed HRP-conjugated goat
anti-human or anti-mouse IgG (1:5000, Sigma, USA)
and developed in an ECL Western blotting system (GE
Healthcare, USA).
2.11. ELISA
The human and rabbit sera were also tested for speciﬁc
IgG antibody levels by ELISA using plates coated (1 lg/
ml) with the rSj myophilin-like puriﬁed protein. The sec-
ondary antibody used in the ELISA was AP-conjugated
goat anti-mouse or goat anti-human IgG (Sigma, USA).
Color reaction was developed by the addition of o-phenyl-
enediamine (OPD) (Sigma, USA) in phosphate buﬀer and
stopped with sulfuric acid. The absorbance was read at
490 nm using a micro plate reader.
The ELISA data were statistically analyzed by a group
t-test, and a P-value <0.05 was regarded as signiﬁcant.
3. Results
3.1. Molecular characterization of Sj myophilin-like protein
The CDS encoding the Sj myophilin-like protein was
successfully subcloned from the cDNA clone pBluescript
II SK(+) sjs2-011 C10 into pET22b. The Sj myophilin-like
clone was 570 bp in length, encoding a protein of 190
amino acid residues (Fig. 1), with a molecular mass of
21.138 kDa, and its isoelectric point (PI) was 8.66 (http://
us.expasy.org/cgi-bin/pi_tool). The amino acid sequence
of Sj myophilin-like is 100% identical to that of Echinococ-
cus granulosus myophilin-like protein (GenBank
AAT46028), and 74% identical to the myophilin antigen
from E. granulosus (GenBank CAA82316), 52% identical
to the calponin of Branchiostoma belcheri (GenBank
BAC16745), 52% identical to the neuronal protein 22 from
Rattus norvegicus (GenBank AAL66341), and 56% identi-
cal to the mp20 from Bombyx mori (GenBank
NP_001040476) (Fig. 1).
3.2. Transcript analysis of Sj myophilin-like
To identify the transcript of the myophilin-like protein
in adult worms, a Northern blot was performed with total
RNA from adult male worms. A distinct signal of approx-
imately 740 bp was observed (Fig. 2A). The size of the sig-
nal corresponds with the molecular size of the full-length
cDNA clone found in the library.
RT-PCR was performed with various stages in order to
detect the expression of myophilin-like mRNA during the
S. japonicum life cycle. As shown in Fig. 2B, the expected
size (570 bp) myophilin-like fragments were ampliﬁed
from all of the cDNA libraries. The RT-PCR results
Fig. 1. Multiple alignment of the deduced amino acid sequences of the Sj myophilin-like protein with the homologs, E. granulosus myophilin-like protein,
myophilin antigen from E. granulosus, calponin of B. belcheri, Mp20 from B. mori, and neuronal protein 22 from R. norvegicus. Gaps are represented by
dashed lines. ‘‘” means that the residues in that column are identical in all sequences in the alignment; ‘‘:” means that conserved substitutions have been
observed; ‘‘.” means that semi-conserved substitutions are observed.
Fig. 2. Gene expression analysis of Sj myophilin-like transcripts. (A)
Northern blot analysis of Sj myophilin-like mRNA expression in S.
japonicum adult worms. Northern blot with 3 lg total RNA from adult
male worms. The transcript of the Sj myophilin-like protein band at
740 bp. (B) RT-PCR analysis of Sj myophilin-like mRNA in diﬀerent
developmental stages. M, molecular weight marker (2000, 1000, 750, 500,
250, 100 bp); E, eggs; Sp, sporocysts; C, cercariae; Hs, hepatic schisto-
somula; A, adults (mixed-gender); P, positive control, plasmid pET22b-Sj
myophilin-like as template; N, no template control. cDNA samples used
were from individual stage cDNA libraries.
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eggs, sporocysts, cercariae, hepatic schistosomula and
adult worms.3.3. Expression and puriﬁcation of rSj myophilin-like protein
IPTG (0.8 mM) eﬃciently induced expression of the rSj
myophilin-like protein and the protein accumulated in
inclusion bodies (Fig. 3A). The apparent molecular mass
of the rSj myophilin-like protein was about 25 kDa. This
band is about 3 kDa bigger than the estimated size deduced
from the sequence data because the recombinant protein
contains an additional 30 amino acids comprising the N-
terminal pelB leader and the C-terminal 6 His tag
sequence. The recombinant protein was subsequently puri-
ﬁed using an aﬃnity chromatography puriﬁcation kit. It
was absorbed by the Ni2+ through its 6 His tag when
passed through the column. The absorbed proteins were
eluted with a linear imidazole gradient as described in Sec-
tion 2 (Fig. 3B, lane 4).
Fig. 3. Expression analysis of the recombinant Sj myophilin-like protein.
Lane M, molecular mass standards. (A) Lane 1, before induction; lane 2,
supernatant after induction; lane 3, precipitate after induction. (B) Lane 4,
puriﬁed protein after aﬃnity chromatography.
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human or mouse sera
Puriﬁed rSj myophilin-like protein (50 ng/well) and
crude extract protein from adult worm (10 lg/well) were
loaded onto SDS–PAGE gels. After electrophoresis and
transfer, the proteins were probed with human or mouse
sera. (Fig. 4). Pooled sera from healthy humans did not rec-
ognize the rSj myophilin-like protein (Fig. 4B, lane 5). In
contrast, the rSj myophilin-like protein was recognized by
a serum pool from schistosomiasis patients (Fig. 4B, lane
6). Polyclonal mouse antisera recognized a band ofFig. 4. Western blot analysis of Sj myophilin-like protein. The samples
loaded were crude protein extract from adult worms (lanes 1 and 2) or rSj
myophilin-like protein (lanes 3–6). (A) Probed with mouse sera. Lanes 1
and 4 probed with pre-immune mouse serum; lanes 2 and 3 probed with
sera from immunized mice. (B) Probed with human sera. Lane 5 probed
with serum pool from healthy humans; lane 6, probed with serum pool
from schistosomiasis japonica patients. An arrow indicates the location of
the rSj myophilin-like protein (25 kDa) or native Sj myophilin-like protein
(22 kDa).22 kDa in the crude protein extract from adult worms
(Fig. 4A lane 2), and this antiserum also recognized the
rSj myophilin-like protein as a band about 25 kDa
(Fig. 4A, lane 3). Neither the crude protein extract nor
the recombinant protein reacted with the pre-immune
mouse serum (Fig. 4A, lanes 1 and 4).
3.5. Immunoﬂuorescence localization of Sj myophilin-like
protein in adult worms
The distribution of rSj myophilin-like protein in adult
worms was investigated by indirect immunoﬂuorescence.
Cryosectioned S. japonicum adults were incubated with
mouse anti-serum and pre-immune mouse serum as con-
trol. The myophilin-like protein was found to be distrib-
uted in the muscle of adult worms (Fig. 5). No
ﬂuorescence was detected in control sections.
3.6. Sj myophilin-like protein antibodies in human sera
A series of ELISA experiments were conducted to detect
antibody levels in human sera using the rSj myophilin-like
protein as antigen (Table 1). Two of the 33 healthy human
serum samples were positive, giving a false positive rate of
6.06% (2/33). Sera (35 of 61) from conﬁrmed schistosomi-
asis patients, were positive, giving a sensitivity of 57.4%
(35/61). The diﬀerence between the two groups was statis-
tically signiﬁcant (P < 0.0001).
3.7. Diminution of antibody levels in treated infected rabbits
Speciﬁc antibody levels in infected rabbits were deter-
mined over time by ELISA using the rSj myophilin-like
protein as antigen (Fig. 5). In the praziquantel-treated
group, the antibody level increased remarkably 9 weeks
after treatment but then decreased to a level almost equal
to that of the pre-infected animals (P > 0.05, data not
shown) 11 weeks after treatment (Fig. 6B). In contrast,
the antibody level of the un-treated group increased
throughout the experiment until 18 weeks after infection,
and the level was clearly diﬀerent from that of the pre-
infected animals (P < 0.05) (Fig. 6A).
4. Discussion
Myophilin was ﬁrst identiﬁed as a muscle-speciﬁc pro-
tein of E. granulosus, where it appeared to be involved in
the regulation of muscle contraction (Martin et al., 1995,
1996). A myophilin-like protein was subsequently identi-
ﬁed from E. granulosus with high similarity (74% amino
acid sequence identity) myophilin. In the present study,
a myophilin-like protein from S. japonicum was identical
to the ortholog from E. granulosus. By mapping the draft
S. japonicum genome sequence, single copy of the myo-
philin-like protein gene was annotated in the S. japoni-
cum genome; it contains four exons segregated by three
introns (data not shown). No homolog of the E. granulo-
Fig. 5. Immunolocalization of the Sj myophilin-like in adult male S. japonicum. (A) Detected with pre-immunized mouse sera; (B) Detected with mouse
anti-serum against Sj myophilin-like protein. Magniﬁcation 400.
Table 1
Anti-Sj22 antibody detection in sera from healths human and schistosomiasis patients
Groups OD490 value ðx SDÞ Positive cut-oﬀðxþ 2SDÞ No. samples Positives no. (%) P-value*
Healths 0.2085 ± 0.0598 0.328 33 2 (6.06) <0.0001
Patients 0.4312 ± 0.2291 61 35 (57.4)
* Group t-test.
Fig. 6. Changes in anti-Sj myophilin-like serum antibody levels in infected
rabbits groups. (A) Group without treatment with praziquantel post-
infection; (B) Group treated with praziquantel at 10 weeks post-infection.
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icum genome (http://lifecenter.sgst.cn), a situation similarto Schistosoma mansoni (Haas et al., 2007; Oliveira,
2007).
To investigate transcription of the S. japonicum myophi-
lin-like protein in diﬀerent life cycle stages, Northern blot-
ting and RT-PCR analysis were undertaken and the results
revealed that transcripts of the myophilin-like protein were
present in eggs, sporocysts, cercariae, hepatic schistosom-
ula and adult worms. This corroborated earlier proteomics
analysis which showed that the myophilin-like protein is
present in the eggs, cercariae, schistosomula and adult
worms of S. japonicum (Liu et al., 2006). We detected the
myophilin-like protein in the muscle of adult worms by
immunoﬂuorescence. Taken together, it appears that the
S. japonicum myophilin-like protein is a muscle protein
and likely plays an important role throughout the life cycle
in the developmental biology of the worm, similar to that
reported for its homolog, calponin, in B. belcheri (Urano
et al., 2003).
The antigenity of rSj myophilin-like protein was exam-
ined by Western blotting, and the level of anti-Sj myophi-
lin-like antibody in sera was assessed by ELISA in
uninfected individuals, schistosomiasis patients, infected
rabbits, including animals treated with praziquantel. The
ELISA results showed that the diﬀerence in anti-myophi-
lin-like protein antibodies between healthy and schistoso-
miasis patients was signiﬁcant (P < 0.0001), and a
diagnostic sensitivity of 57.4% (35/61) was obtained.
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lin-like protein is insuﬃciently high, it could be useful
when combined with other antigen(s). In rabbits, the anti
Sj myophilin-like protein antibody levels signiﬁcantly
increased after S. japonicum infection. In the group trea-
ted with praziquantel, the antibody level had decreased
10 weeks after infection, to the pre-infection level,
whereas it increased continually in un-treated groups.
Together with the antibody level diﬀerences between
healthy and schistosomiasis patients, these results suggest
that detection of anti-S. japonicum myophilin-like anti-
bodies could be used to monitor the treatment eﬃcacy
of praziquantel.
In conclusion, we identiﬁed a novel muscle myophilin-
like protein from S. japonicum. The rSj myophilin-like pro-
tein may be useful as an adjunct immunodiagnosis antigen
for schistosomiasis as well as a marker of drug treatment
eﬃcacy.
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